Literature DB >> 3489755

Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients.

H L Coppin, H O McDevitt.   

Abstract

Ninety percent of individuals with ankylosing spondylitis (AS) express HLA-B27. To determine if HLA-B27 coding sequences from normal vs AS individuals show differences that might relate to the etiology of the disease, the gene coding for this allele was cloned from three different partial genomic libraries. These libraries were made with DNA from three different cell lines expressing HLA-B27: MRWC (HLA-B27, 14), obtained from an AS patient; KCA (HLA-B27, w44), obtained from a known normal individual; and MVL (HLA-B27, 27), a homozygous consanguineous cell line of unknown origin. To increase the number of clones coding for the HLA-B locus, partial libraries were made using a complete Eco RI digestion of genomic DNA in the lambda vector 607. The libraries were screened with two probes; one probe hybridizes to all HLA-A, B, C class I genes, and the other to a small subpopulation of class I genes, including the B locus. DNA from clones hybridizing with both probes was transfected into murine L cells. Cell surface expression of HLA-B27 on murine L cells was detected with a polymorphic monoclonal antibody (ME1) specific for HLA-B27, 7, 22. DNA from those clones positive for HLA-B27 by transfection was subcloned into the Xba I site of M13mp18 and the DNA sequence for exons 2 through 4 (encoding domains alpha 1, alpha 2, and alpha 3) was determined by the dideoxy technique by using synthetic oligonucleotide primers or the M13 primer. The resulting sequences show no difference between HLA-B27 alpha 1, alpha 2, alpha 3 domains from a known AS patient and a known normal individual.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489755

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.

Authors:  B S Breur-Vriesendorp; A J Dekker-Saeys; P Ivanyi
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

Review 2.  Immunoregulation of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

3.  HLA-B27 and the causes of arthritis: does molecular biology help?

Authors:  J R Archer; V R Winrow
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

4.  Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein.

Authors:  A Toubert; M Hamachi; C Raffoux; M S Park; D T Yu
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.

Authors:  C M Higgins; T Lund; M E Shipley; A Ebringer; M Sadowska-Wroblewska; R K Craig
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

Review 6.  Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?

Authors:  R Lahesmaa; M Skurnik; P Toivanen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

7.  Sulphydryl reactivity of the HLA-B27 epitope: accessibility of the free cysteine studied by flow cytometry.

Authors:  L MacLean; M Macey; M Lowdell; S Badakere; M Whelan; D Perrett; J Archer
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

8.  Ankylosing spondylitis: an autoimmune disease?

Authors:  H J Lakomek; M Plomann; C Specker; M Schwochau
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

9.  Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes.

Authors:  C L Nickerson; J Hanson; C S David
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.